Related Experiment Video
Updated: Aug 8, 2025

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
Published on: March 29, 2019
miRNAs and arsenic-induced carcinogenesis
Alexandra N Nail1, Ana P Ferragut Cardoso1, Lakyn K Montero1
1Department of Pharmacology and Toxicology, Center for Integrative Environmental Health Science, University of Louisville, Louisville, KY, United States.
Abstract:
Arsenic-induced carcinogenesis is a worldwide health problem. Identifying the molecular mechanisms responsible for the induction of arsenic-induced cancers is important for developing treatment strategies. MicroRNA (miRNA) dysregulation is known to affect development and progression of human cancer. Several studies have identified an association between altered miRNA expression in cancers from individuals chronically exposed to arsenic and in cell models for arsenic-induced carcinogenesis. This chapter provides a comprehensive review for miRNA dysregulation in arsenic-induced cancer.
Insights
Arsenic exposure causes cancer worldwide. This review details how microRNA (miRNA) changes contribute to arsenic-induced cancers, aiding in developing new treatments.
Area of Science:
- Environmental Health Sciences
- Molecular Biology
- Cancer Research
Background:
- Arsenic-induced carcinogenesis is a significant global health concern.
- Understanding the molecular drivers of arsenic-related cancers is crucial for effective treatment strategies.
- MicroRNA (miRNA) dysregulation is increasingly recognized as a key factor in cancer development and progression.
Approach:
- This chapter comprehensively reviews the current literature on miRNA dysregulation in arsenic-induced cancers.
- It examines studies linking altered miRNA expression in individuals with chronic arsenic exposure to cancer development.
- The review also includes findings from cell models investigating arsenic-induced carcinogenesis.
Key Points:
- Altered miRNA expression is consistently observed in cancers associated with chronic arsenic exposure.
- miRNA dysregulation plays a role in the molecular mechanisms underlying arsenic-induced carcinogenesis.
- Specific miRNAs may serve as biomarkers or therapeutic targets for arsenic-related cancers.
Conclusions:
- miRNA dysregulation is a critical component of arsenic-induced carcinogenesis.
- Further research into miRNA's role can lead to novel diagnostic and therapeutic approaches for arsenic-related cancers.
- Addressing miRNA alterations presents a promising avenue for combating arsenic-induced cancer globally.
Related Concept Videos
Mutagenicity and Carcinogenicity
MicroRNAs
Experimental RNAi
Induced Pluripotent Stem Cells
Somatic...
Spontaneous and Induced Mutations

